Aclarion, Inc. has announced that its innovative Nociscan technology is now available at Goodman Campbell Brain & Spine in Indiana, marking a significant step in the fight against chronic low back pain. This partnership brings a new diagnostic tool to one of the nation’s leading neurosurgery and spine care networks, known for its commitment to advanced treatment methods. Nociscan uses Magnetic Resonance Spectroscopy (MRS) to identify the specific discs causing pain, offering insights that traditional MRI scans cannot provide.

For people suffering from chronic low back pain, this development could mean more accurate diagnoses and better treatment options. Nociscan has shown a remarkable 97% success rate in surgeries when the discs identified as painful are treated. This is crucial for the approximately 266 million individuals worldwide dealing with degenerative spine disease and related pain, as it can lead to more targeted and effective interventions, ultimately improving quality of life.

The technology is in its early stages of adoption, with its availability expanding across the U.S. as more healthcare providers recognize its potential. Nociscan is designed to complement existing diagnostic tools, providing non-invasive insights that can help physicians tailor their treatment strategies. While this technology is promising, it is important to note that it is still being integrated into clinical practice, and ongoing research will further establish its efficacy and application.

If you’re dealing with chronic low back pain, consider discussing the Nociscan option with your healthcare provider to see if it could be a beneficial part of your treatment plan.

For more information, visit the original announcement from GlobeNewswire.